Hypoinsulinemic Hypoglycemia with Hemihypertrophy: A Patient Guide

Hypoinsulinemic hypoglycemia with hemihypertrophy is an extremely rare clinical phenotype—a specific pattern of physical and biochemical features—that occurs when the body’s internal growth and energy signals are inappropriately activated. This guide is educational information for a suspected or confirmed phenotype, not a diagnosis. In a typical body, the hormone insulin acts as a key that unlocks cells so they can take in sugar for energy. In some forms of this condition, however, an activating insulin-signaling variant causes the signaling pathway inside the cells to stay active even when insulin is not present. This creates a state of pseudohyperinsulinism, where the cells continuously vacuum up sugar from the blood, leading to frequent and sometimes severe episodes of low blood sugar ^[1][2].

Because these same signaling pathways also control how fast cells divide and grow, the activation often leads to physical overgrowth. This most commonly appears as hemihypertrophy (or lateralized overgrowth), where one side of the body, a specific limb, or the tongue grows faster and larger than the rest. This dual effect—low blood sugar and asymmetric growth—is the hallmark of the condition, distinguishing it from more common metabolic disorders. It is fundamentally different from Congenital Hyperinsulinism (CHI); while the symptoms of low blood sugar look the same, the underlying biological mechanism is located inside the cell’s signaling machinery rather than in the pancreas’s ability to produce insulin ^[3][2].

Living with this condition requires a specialized approach to daily management and long-term safety. Because the body acts as if it is constantly flooded with insulin, the primary goal of treatment is to provide a steady, uninterrupted supply of energy through frequent feedings and slow-release carbohydrates. Traditional medications used for other forms of hypoglycemia are often ineffective here because they target insulin production, which is already low. Instead, care focuses on customized nutritional strategies and, in some cases, targeted therapies that aim to dial down the overactive signaling pathway ^[4][2].

Beyond managing blood sugar, families may also navigate a schedule of health screenings. Depending on the diagnosis, the same growth signals that cause hemihypertrophy can slightly increase the risk for certain childhood tumors in the kidneys or liver. For this reason, regular ultrasounds and blood tests are a standard part of life for some patients. While this monitoring can be a source of anxiety, it serves as a vital safety net, ensuring that any changes are caught and addressed as early as possible. Most importantly, managing this condition is a team effort. By working with a multidisciplinary group of endocrinologists, geneticists, and oncologists (if indicated), families can create a stable environment where their child can grow, develop, and thrive ^[5][6].